LMR Partners’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-540,984
Closed -$103K 1581
2025
Q3
$103K Buy
540,984
+340,984
+170% +$409K ﹤0.01% 1281
2025
Q2
$340K Buy
+200,000
New +$337K ﹤0.01% 1030

LMR Partners's EPIX Position: Q4 2025 in Review

LMR Partners sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 540,984 shares — an estimated $103K sold.

LMR Partners first reported a position in EPIX in Q2 2025 and held it in 2 quarters. The position peaked at $340K in Q2 2025. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

  • LMR Partners reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
  • LMR Partners sold 540,984 ESSA Pharma shares in Q4 2025, an estimated $103K.
  • LMR Partners first reported a position in ESSA Pharma in Q2 2025 and held it in 2 quarters.
  • LMR Partners's ESSA Pharma position peaked at $340K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on LMR Partners's 13F filing for Q4 2025, filed 17 Feb 2026.